by Co-Diagnostics | May 27, 2020 | News Release
Salt Lake City, Utah – May 27, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX) (the Company), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that Company CEO Dwight Egan has been invited to present... by Co-Diagnostics | May 26, 2020 | News Release
Tissue from presymptomatic patient in Italy was found to contain SARS-CoV-2 using Company’s Logix Smart™ COVID-19 test kit Salt Lake City, Utah – May 26, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX) (the Company), a molecular diagnostics company with a unique, patented... by Co-Diagnostics | May 14, 2020 | News Release
Salt Lake City, Utah – May 12, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX) (the Company), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, releases the prepared remarks for the Q1 2020 conference call scheduled... by Co-Diagnostics | May 14, 2020 | News Release
Company reports robust sales of COVID-19 tests as Co-Diagnostics generates net profit through middle of second quarter Salt Lake City, Utah – May 14, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX) (the Company), a molecular diagnostics company with a unique, patented... by Co-Diagnostics | May 12, 2020 | Uncategorized
Salt Lake City, Utah – May 12, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX) (the Company), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that it will release its first quarter 2020 earnings on... 